BuzBuz Capital Corp. Announces Further Update to Its 2019 Annual Filings and Continuous Disclosure

June 04, 2020 10:28 AM EDT | Source: NuGen Medical Devices Inc.

Toronto, Ontario--(Newsfile Corp. - June 4, 2020) - BuzBuz Capital Corp. (TSXV: BZBZ.P) (the "Company") announces that, further to its news release dated April 29, 2020, the Company has delayed the filing of its audited annual financial statements, management's discussion and analysis, as well as the associated CEO and CFO certifications for the year ended December 31, 2019 (collectively, the "Required Disclosure") pursuant to OSC Instrument 51-502.

In addition, the Company is announcing that filing of the interim financial statements, management's discussion and analysis, and related certifications for the interim period ended March 31, 2020 (the "Interim Filings") due June 1, 2020, will be postponed pursuant to OSC Instrument 51-502 until filing of the Required Disclosure has been completed. The Company is continuing to work diligently to file the Interim Filings by July 14, 2020.

Other than as disclosed herein or under the Company's profile on SEDAR at www.sedar.com, the Company confirms that there have been no material business developments since November 29, 2019, being the filing date of its last interim financial statements.

The Company's management and other insiders are subject to an insider trading black-out policy that reflects the principles in section 9 of National Policy 11-207.

For further information please contact:

Richard Buzbuzian, President and CEO
BuzBuz Capital Corp.
Phone: (647) 501-3290

Forward Looking Information

This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. More particularly and without limitation, this news release contains forward‐looking statements and information relating to the filing of the Required Disclosure and other matters. The forward‐looking statements and information are based on certain key expectations and assumptions made by management of the Company. As a result, there can be no assurance that filings will occur in the timelines provided herein. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward‐looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. The forward-looking statements in this press release include the Company's intentions regarding the filing of the Required Disclosure. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/57274

info